Barbara Cipriani

Barbara Cipriani is currently the Vice President, Biology and Head of Biology at Pathios Therapeutics. Barbara has extensive experience in leading preclinical biology strategies and addressing biological challenges in cancer immunology. Prior to their current role, Barbara worked at Vertex Pharmaceuticals as a Sr. Research Scientist, overseeing the advancement of new target ideas and managing preclinical programs. Barbara also previously worked at Merck in the area of cancer vaccine research. Barbara holds a PhD in Neuroimmunology from Albert Einstein College of Medicine and Tor Vergata University.